Armata Pharmaceuticals ARMP
NYSE ARMP
$5.10 +0.68 (+15.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2013 - 2014)

Armata Pharmaceuticals (ARMP) posted Amortizatization of Intangibles of $8000.0 for Q1 2014, up 900.0% sequentially from -$1000.0 in Q4 2013, and down 97.43% YoY from $311000.0 in Q1 2013.

Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2013 - 2014) Analysis & Trends

Armata Pharmaceuticals has reported Amortizatization of Intangibles for 2 years, with the latest figure at $8000.0 in Q1 2014.

  • Quarterly Amortizatization of Intangibles fell 97.43% year-over-year to $8000.0 in Q1 2014, while the trailing twelve-month figure through Dec 2014 was $8000.0 (down 99.7% YoY) and the FY2013 annual result came in at $2.6 million, changed N/A from the prior year.
  • Amortizatization of Intangibles grew to $8000.0 in Q1 2014 per ARMP's latest filing, from -$1000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $2.3 million in Q2 2013 and troughed at -$1000.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Armata Pharmaceuticals 182.82 Mn 158.82 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2014 8,000.00
Mar 31, 2014 8,000.00
Dec 31, 2013 -1,000.00
Dec 31, 2013 -1,000.00
Jun 30, 2013 2.33 Mn
Jun 30, 2013 2.33 Mn
Mar 31, 2013 311,000.00
Mar 31, 2013 311,000.00